- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有615家主力机构披露2025-12-31报告期持股数据，持仓量总计6.51亿股，占流通A股41.22%
- 波段诊断：
-
技术面诊股
诊断结果：5.2技术面打败了53%的股票
技术面评分前10的股票
近期的平均成本为11.51元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为11.51元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"11.51","date":1782028851,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2026.06.22","stock":"-0.08","trade":null,"ind":"2.13"},{"date":"2026.06.18","stock":"1.03","trade":null,"ind":"0.94"},{"date":"2026.06.17","stock":"-0.85","trade":null,"ind":"1.31"},{"date":"2026.06.16","stock":"-1.17","trade":null,"ind":"0.93"},{"date":"2026.06.15","stock":"1.62","trade":null,"ind":"3.79"},{"date":"2026.06.12","stock":"2.53","trade":null,"ind":"0.75"},{"date":"2026.06.11","stock":"-2.55","trade":null,"ind":"-0.68"},{"date":"2026.06.10","stock":"0.17","trade":null,"ind":"-2.06"},{"date":"2026.06.09","stock":"0.17","trade":null,"ind":"3.02"},{"date":"2026.06.08","stock":"-3.62","trade":null,"ind":"-3.22"},{"date":"2026.06.05","stock":"0.00","trade":null,"ind":"-2.21"},{"date":"2026.06.04","stock":"-1.86","trade":null,"ind":"-0.27"},{"date":"2026.06.03","stock":"-1.43","trade":null,"ind":"0.73"},{"date":"2026.06.02","stock":"-0.79","trade":null,"ind":"1.63"},{"date":"2026.06.01","stock":"0.48","trade":null,"ind":"-1.51"},{"date":"2026.05.29","stock":"1.45","trade":null,"ind":"-1.81"},{"date":"2026.05.28","stock":"-1.11","trade":null,"ind":"0.80"},{"date":"2026.05.27","stock":"-0.95","trade":null,"ind":"-0.88"},{"date":"2026.05.26","stock":"-1.55","trade":null,"ind":"0.12"},{"date":"2026.05.25","stock":"-0.85","trade":null,"ind":"1.66"},{"date":"2026.05.22","stock":"-0.46","trade":null,"ind":"2.30"}]
乐普医疗,深证成指,医疗器械指数
压力支撑
该股压力位为11.50元，支撑位为11.20元。
[{"text":"\u538b\u529b\u4f4d","value":"11.50","date":1782057600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"11.20","date":1782057600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.7资金面打败了22%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月22日 20:30
| 机构今日流向(万元) | -1107.46 | 机构5日流向(万元) | -3007.54 |
| 机构10日流向(万元) | -5135.35 | 机构20日流向(万元) | -11106.10 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加4816.12万股，其中基金净减仓83家，主力净增仓281家，请投资者中长期谨慎为宜。
截止2025-12-31，共615家主力机构（基金609家，保险公司1家，一般法人5家），持仓量总计65083.96万股，占流通A股41.22%
其中，基金持仓与2025-06-30相比：
增仓：68家 ，增持 2149.24万股
减仓：151家 ，减持 4074.80万股
新出现在主力名单中：376家 ，持有8292.89万股
从主力名单中消失：95家 ，原持有2863.57万股
其中，基金持仓与2025-06-30相比：
增仓：68家 ，增持 2149.24万股
减仓：151家 ，减持 4074.80万股
新出现在主力名单中：376家 ，持有8292.89万股
从主力名单中消失：95家 ，原持有2863.57万股
消息面诊股
诊断结果：5.6消息面打败了24%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 乐普医疗：6月18日获融资买入2554.90万元
2026-06-22 - 最新支架国采中选结果：外资全部"留场"，但大赢家是
2026-06-18 - 2026年中国医疗耗材行业发展现状、竞争格局及趋势
2026-06-18 - 牙科医疗板块走高，爱迪特涨停
2026-06-18 - 乐普医疗：6月17日获融资买入1453.32万元
2026-06-18 - 乐普医疗2025年全年每10股派1.6275元
2026-06-17 - 申万宏源：PDRN化妆品前景广阔 国内企业蓄势待发
2026-06-17 - 乐普医疗：6月16日获融资买入1736.10万元
2026-06-17 - 乐普医疗：6月15日获融资买入2069.43万元
2026-06-16 - 乐普医疗：6月12日获融资买入2254.09万元
2026-06-15
消息列表
| 一般消息 | 募资投向 | 2026-06-05 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-23 |
| 利好 | 分红转增 | 10派1.6275元(含税) | 2026-04-23 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-23 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-14 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-26 |
| 一般消息 | 高管变动 | 连续任职时间将满六年 | 2026-03-20 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2026-01-28 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-10 |
| 利好 | 分红转增 | 10派1.6275元(含税) | 2025-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-21 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 1条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了55%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.06.22","price":"2.13","value":null},{"date":"2026.06.18","price":"0.94","value":null},{"date":"2026.06.17","price":"1.31","value":null},{"date":"2026.06.16","price":"0.93","value":null},{"date":"2026.06.15","price":"3.79","value":null},{"date":"2026.06.12","price":"0.75","value":null},{"date":"2026.06.11","price":"-0.68","value":null},{"date":"2026.06.10","price":"-2.06","value":null},{"date":"2026.06.09","price":"3.02","value":null},{"date":"2026.06.08","price":"-3.22","value":null},{"date":"2026.06.05","price":"-2.21","value":null},{"date":"2026.06.04","price":"-0.27","value":null},{"date":"2026.06.03","price":"0.73","value":null},{"date":"2026.06.02","price":"1.63","value":null},{"date":"2026.06.01","price":"-1.51","value":null},{"date":"2026.05.29","price":"-1.81","value":null},{"date":"2026.05.28","price":"0.80","value":null},{"date":"2026.05.27","price":"-0.88","value":null},{"date":"2026.05.26","price":"0.12","value":null},{"date":"2026.05.25","price":"1.66","value":null},{"date":"2026.05.22","price":"2.30","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 爱迪特 | 68.33% | 63.79% | 5.3分 |
| 2 | 力诺药包 | 39.04% | 30.00% | 6.1分 |
| 3 | 正川股份 | 17.61% | 3.42% | 6.1分 |
| 4 | 万孚生物 | 7.45% | -3.54% | 4.1分 |
| 5 | 仁度生物 | 3.87% | 7.27% | 5.4分 |
| 6 | 威高血净 | 1.98% | -2.49% | 5.7分 |
| 8 | 洁特生物 | 1.27% | 16.70% | 4.8分 |
| 10 | 天智航 | 0.73% | 9.66% | 5.2分 |
| 12 | 华兰股份 | -0.08% | 8.03% | 5.4分 |
| 14 | 麦克奥迪 | -1.72% | 8.89% | 6.1分 |
| 16 | 赛诺医疗 | -3.14% | -4.28% | 4.6分 |
| 18 | 赛科希德 | -4.44% | 7.26% | 5.5分 |
| 20 | 理邦仪器 | -4.50% | -2.52% | 5.5分 |
| 22 | 热景生物 | -4.85% | -1.86% | 4.6分 |
| 24 | 东方海洋 | -4.89% | -3.85% | 4.3分 |
| 26 | 三鑫医疗 | -4.94% | -1.39% | 4.7分 |
| 28 | 鱼跃医疗 | -5.30% | -3.04% | 5.0分 |
| 30 | 五洲医疗 | -5.65% | -6.48% | 3.8分 |
| 32 | 迈瑞医疗 | -6.33% | -6.08% | 4.5分 |
| 34 | 康德莱 | -6.45% | -2.47% | 5.0分 |
| 36 | - | -6.72% | -1.58% | 分 |
| 38 | 九强生物 | -7.24% | -2.25% | 4.7分 |
| 40 | - | -7.63% | 11.82% | 分 |
| 42 | 康拓医疗 | -8.21% | -8.91% | 4.1分 |
| 44 | - | -8.77% | 0.95% | 分 |
| 46 | 新华医疗 | -8.87% | -5.65% | 4.7分 |
| 48 | *ST海利 | -9.58% | -3.21% | 3.4分 |
| 50 | - | -9.81% | 0.46% | 分 |
| 52 | 心脉医疗 | -10.05% | -4.81% | 5.0分 |
| 54 | *ST明德 | -10.21% | -0.41% | 3.6分 |
| 56 | - | -10.44% | -0.89% | 分 |
| 58 | 正海生物 | -10.70% | -0.20% | 4.8分 |
| 60 | 昊海生科 | -11.05% | -1.58% | 4.5分 |
| 62 | 美康生物 | -11.37% | -3.25% | 4.2分 |
| 64 | 春立医疗 | -11.68% | -2.12% | 5.2分 |
| 66 | 戴维医疗 | -11.92% | -1.33% | 4.2分 |
| 68 | 天臣医疗 | -12.29% | -1.38% | 4.8分 |
| 70 | 基蛋生物 | -12.35% | -0.50% | 4.7分 |
| 72 | 天益医疗 | -12.61% | 6.54% | 5.8分 |
| 74 | - | -13.00% | 0.80% | 分 |
| 76 | 康为世纪 | -13.13% | 6.64% | 4.8分 |
| 78 | 普门科技 | -13.20% | -4.06% | 5.2分 |
| 80 | 凯普生物 | -13.43% | 0.56% | 4.3分 |
| 82 | 科华生物 | -13.76% | -3.74% | 4.8分 |
| 84 | 南微医学 | -13.77% | -5.82% | 5.2分 |
| 86 | 英诺特 | -13.94% | -2.39% | 5.1分 |
| 88 | 中源协和 | -14.05% | -3.90% | 4.5分 |
| 90 | 东方生物 | -14.10% | -2.48% | 4.1分 |
| 92 | 超研股份 | -14.31% | -3.41% | 4.9分 |
| 94 | 尚荣医疗 | -14.50% | -5.03% | 4.1分 |
| 96 | 爱博医疗 | -14.63% | -3.44% | 4.6分 |
| 98 | 国发股份 | -14.80% | 2.24% | 4.4分 |
| 100 | - | -14.96% | -3.79% | 分 |
| 102 | ST迪瑞 | -15.02% | -4.61% | 4.0分 |
| 104 | 达安基因 | -15.78% | 0.19% | 4.5分 |
| 106 | 维力医疗 | -16.18% | -2.81% | 4.7分 |
| 108 | 硕世生物 | -16.96% | -5.78% | 4.7分 |
| 110 | 透景生命 | -17.17% | -3.17% | 4.0分 |
| 112 | 万东医疗 | -17.44% | -2.59% | 4.8分 |
| 114 | 英科医疗 | -17.74% | -13.82% | 3.9分 |
| 116 | 浩欧博 | -18.27% | 4.08% | 4.5分 |
| 118 | 山外山 | -18.82% | -1.60% | 6.3分 |
| 120 | 爱朋医疗 | -19.07% | -0.63% | 4.1分 |
| 122 | 奥精医疗 | -19.14% | -4.62% | 4.1分 |
| 124 | 亚辉龙 | -19.63% | -5.06% | 4.2分 |
| 126 | 北芯生命 | -20.41% | 2.54% | 5.6分 |
| 128 | 之江生物 | -21.23% | -4.44% | 4.4分 |
| 130 | 安必平 | -21.41% | -4.25% | 4.3分 |
| 132 | 拱东医疗 | -21.91% | -4.88% | 5.2分 |
| 134 | 健信超导 | -23.53% | -3.49% | 5.6分 |
| 136 | 三友医疗 | -24.66% | -2.33% | 4.3分 |
| 138 | 福瑞医科 | -26.76% | -5.86% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 58/244 ， 49/244。
[{"date":"2026-03-31","value":"1.52","vol":"1.15"},{"date":"2025-12-31","value":"6.14","vol":"2.66"},{"date":"2025-09-30","value":"6.29","vol":"2.97"},{"date":"2025-06-30","value":"4.46","vol":"2.34"},{"date":"2025-03-31","value":"2.46","vol":"1.15"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.52 | 6.14 | 6.29 | 4.46 | 2.46 |
| 行业(%) | 1.15 | 2.66 | 2.97 | 2.34 | 1.15 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"62.03","vol":"52.18"},{"date":"2025-12-31","value":"64.01","vol":"51.61"},{"date":"2025-09-30","value":"64.21","vol":"51.74"},{"date":"2025-06-30","value":"64.26","vol":"52.05"},{"date":"2025-03-31","value":"64.03","vol":"51.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
62.03 | 64.01 | 64.21 | 64.26 | 64.03 |
| 行业(%) | 52.18 | 51.61 | 51.74 | 52.05 | 51.74 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 88/244 ， 86/244。
[{"date":"2026-03-31","value":"-3.70","vol":"5.49"},{"date":"2025-12-31","value":"6.22","vol":"1.44"},{"date":"2025-09-30","value":"3.20","vol":"0.26"},{"date":"2025-06-30","value":"-0.43","vol":"-1.09"},{"date":"2025-03-31","value":"-9.67","vol":"-0.12"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-3.70 | 6.22 | 3.20 | -0.43 | -9.67 |
| 行业(%) | 5.49 | 1.44 | 0.26 | -1.09 | -0.12 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-34.80","vol":"-16.14"},{"date":"2025-12-31","value":"289.57","vol":"-25.45"},{"date":"2025-09-30","value":"22.35","vol":"-15.37"},{"date":"2025-06-30","value":"-0.91","vol":"-18.14"},{"date":"2025-03-31","value":"-21.44","vol":"-2.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-34.80 | 289.57 | 22.35 | -0.91 | -21.44 |
| 行业(%) | -16.14 | -25.45 | -15.37 | -18.14 | -2.57 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 90/244 ， 91/244。
[{"date":"2026-03-31","value":"0.06","vol":"0.08"},{"date":"2025-12-31","value":"0.26","vol":"0.35"},{"date":"2025-09-30","value":"0.20","vol":"0.25"},{"date":"2025-06-30","value":"0.14","vol":"0.17"},{"date":"2025-03-31","value":"0.07","vol":"0.08"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.06 | 0.26 | 0.20 | 0.14 | 0.07 |
| 行业(次) | 0.08 | 0.35 | 0.25 | 0.17 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.32","vol":"0.55"},{"date":"2025-12-31","value":"1.15","vol":"2.33"},{"date":"2025-09-30","value":"0.86","vol":"1.66"},{"date":"2025-06-30","value":"0.59","vol":"1.12"},{"date":"2025-03-31","value":"0.31","vol":"0.54"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.32 | 1.15 | 0.86 | 0.59 | 0.31 |
| 行业(次) | 0.55 | 2.33 | 1.66 | 1.12 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"16.44","vol":"0.09"},{"date":"2025-12-31","value":"32.66","vol":"32.02"},{"date":"2025-09-30","value":"23.98","vol":"14.74"},{"date":"2025-06-30","value":"13.31","vol":"15.54"},{"date":"2025-03-31","value":"24.13","vol":"4.16"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 16.44 | 32.66 | 23.98 | 13.31 | 24.13 |
| 行业 | 0.09 | 32.02 | 14.74 | 15.54 | 4.16 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.89","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.86","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.89 | - | 0.86 | - |
| 行业 | 0.00 | 1.59 | 0.01 | 1.57 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 17/244 ， 30/244。
[{"date":"2026-03-31","value":"2.38","vol":"6.20"},{"date":"2025-12-31","value":"2.01","vol":"5.29"},{"date":"2025-09-30","value":"1.89","vol":"5.66"},{"date":"2025-06-30","value":"1.79","vol":"5.47"},{"date":"2025-03-31","value":"1.82","vol":"5.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.38 | 2.01 | 1.89 | 1.79 | 1.82 |
| 行业 | 6.20 | 5.29 | 5.66 | 5.47 | 5.80 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.71","vol":"5.06"},{"date":"2025-12-31","value":"1.41","vol":"4.14"},{"date":"2025-09-30","value":"1.28","vol":"4.51"},{"date":"2025-06-30","value":"1.20","vol":"4.35"},{"date":"2025-03-31","value":"1.27","vol":"4.69"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.71 | 1.41 | 1.28 | 1.20 | 1.27 |
| 行业 | 5.06 | 4.14 | 4.51 | 4.35 | 4.69 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 31/244 ， 31/244。
[{"date":"2026-03-31","value":"29.75","vol":"21.96"},{"date":"2025-12-31","value":"32.06","vol":"22.90"},{"date":"2025-09-30","value":"30.71","vol":"22.07"},{"date":"2025-06-30","value":"31.39","vol":"22.01"},{"date":"2025-03-31","value":"32.00","vol":"21.02"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
29.75 | 32.06 | 30.71 | 31.39 | 32.00 |
| 行业(%) | 21.96 | 22.90 | 22.07 | 22.01 | 21.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.46","vol":"0.39"},{"date":"2025-12-31","value":"0.52","vol":"0.40"},{"date":"2025-09-30","value":"0.49","vol":"0.71"},{"date":"2025-06-30","value":"0.50","vol":"0.58"},{"date":"2025-03-31","value":"0.52","vol":"0.56"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.46 | 0.52 | 0.49 | 0.50 | 0.52 |
| 行业(%) | 0.39 | 0.40 | 0.71 | 0.58 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 东方证券 | 2026-05-28 | 买入 | |
| 华泰证券 | 2026-05-26 | 买入 | 买入 |
| 东方财富证券 | 2026-05-25 | 增持 | |
| 中信建投证券 | 2026-05-20 | 买入 | |
| 兴业证券 | 2026-05-18 | 增持 | |
| 国联民生 | 2026-05-02 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"22.04","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"12.58","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"2.47","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"9.62","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"11.12","blueLineValue":"0.60","type":"YC"}]